Company / Revenue
Veracyte, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$517.1M
FY2025
5-year range
$219.5M / $517.1M
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
#116 of 150
Health Care
What the data says
Veracyte, Inc.'s revenue of $517M is lower than 77% of companies in the Health Care sector (FY2025). Revenue has increased for 5 consecutive years, from $117M in FY2020 to $517M in FY2025.
Based on SEC 10-K filings.
$517M in FY2025 with a 5-year CAGR of +34.5%.
Improved from $361M to $517M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +20.4%
- 5-Year CAGR
- +34.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 150This company $517.1M Sector average $19.5B
▼
-97.3% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s revenue has grown for 5 consecutive years.
- 5-year CAGR of +34.5%, indicating consistent growth.
- In FY2025, revenue increased 16.0% year-over-year.
- Ranks #116 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $517.1M | +16.0% |
| FY2024 | $445.8M | +23.5% |
| FY2023 | $361.1M | +21.8% |
| FY2022 | $296.5M | +35.1% |
| FY2021 | $219.5M | +86.8% |
| FY2020 | $117.5M | -2.4% |
| FY2019 | $120.4M | +30.8% |
| FY2018 | $92.0M | +27.9% |
| FY2017 | $72.0M | +10.6% |
| FY2016 | $65.1M | +31.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026